US Stock MarketDetailed Quotes

ATHE Alterity Therapeutics

Watchlist
  • 1.9612
  • +0.0012+0.06%
Close May 21 16:00 ET
17.12MMarket Cap-980P/E (TTM)

About Alterity Therapeutics Company

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Company Profile

SymbolATHE
Company NameAlterity Therapeutics
Listing DateSep 5, 2002
Founded1997
CEODr. David A. Stamler,M.D.
MarketNASDAQ
Employees11
Securities TypeDR
ADS Ratio1.0 : 600.0
Fiscal Year Ends06-30
Address350 Collins Street,Level 14,Suite 4
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9349-4906

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David A. Stamler,M.D.
  • Chief Executive Officer
  • 1.62M
  • Kathryn J.E. Andrews
  • Chief Financial Officer
  • 359.79K
  • Geoffrey Paul Kempler
  • Chairman of the Board
  • 387.80K
  • Lawrence B. Gozlan
  • Director
  • 107.50K
  • Peter A. Marks
  • Independent Director
  • 70.00K
  • Brian Derek Meltzer
  • Independent Director
  • 70.00K
  • Phillip A. Hains
  • Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg